In the present study, we have tried to establish the correlation between changes in Zeta potential with that of cell surface permeability using bacteria (Escherichia coli and Staphylococcus aureus). An effort has been made to establish Zeta potential as a possible marker for the assessment of membrane damage, with a scope for predicting alteration of cell viability. Cationic agents like, cetyl trimethyl ammonium bromide and polymyxin B were used for inducing alteration of Zeta potential, and the changes occurring in the membrane permeability were studied. In addition, assessment of poly-dispersity index (PDI), cell viability along with confocal microscopic analysis were performed. Based on our results, it can be suggested that alteration of Zeta potential may be correlated to the enhancement of membrane permeability and PDI, and it was observed that beyond a critical point, it leads to cell death (both Gram-positive and Gram-negative bacteria). The present findings can not only be used for studying membrane active molecules but also for understanding the surface potential versus permeability relationship.

Response surface methodology (RSM) serves as a valuable tool in pharmaceutical formulation development, facilitating the optimization of drug formulations by systematically exploring the effects of multiple variables on desired responses. This methodology involves the design of experiments to generate mathematical models that predict the relationship between formulation parameters and critical quality attributes. By utilizing statistical techniques such as factorial design, central composite design, and Box-Behnken design, RSM enables the identification of optimal formulation conditions while minimizing the number of experimental trials. Across iterative experimentation and model refinement, RSM assists in understanding the complex interactions between formulation components, process variables, and product characteristics. In this review, we discuss the application of RSM in pharmaceutical formulation studies, highlighting its efficacy in optimizing drug delivery systems, enhancing product stability, and ensuring quality control. In addition, we explore recent advancements in RSM-driven approaches, including its integration with computational modeling and artificial intelligence techniques for enhanced formulation design and process optimization. Overall, RSM offers a systematic and efficient approach for developing robust pharmaceutical formulations, thereby accelerating the drug development process and improving therapeutic outcomes.

This study investigates the efficacy of modified Albizia procera gum as a release-retardant polymer in Diltiazem hydrochloride (DIL) matrix tablets. Carboxymethylated Albizia procera gum (CAP) and ionically crosslinked carboxymethylated Albizia procera gum (Ca-CAP) were utilized, with Ca-CAP synthesized via crosslinking CAP with calcium ions (Ca2+) using calcium chloride (CaCl2). Fourier Transform (FT) IR analysis affirmed polymer compatibility, while differential scanning calorimetry (DSC) and X-ray diffraction (XRD) assessed thermal behavior and crystallinity, respectively. Zeta potential analysis explored surface charge and electrostatic interactions, while rheology examined flow and viscoelastic properties. Swelling and erosion kinetics provided insights into water penetration and stability. CAP’s carboxymethyl groups (–CH2–COO−) heightened divalent cation reactivity, and crosslinking with CaCl2 produced Ca-CAP through –CH2–COO− and Ca2+ interactions. Structural similarities between the polymers were revealed by FTIR, with slight differences. DSC indicated modified thermal behavior in Ca-CAP, while Zeta potential analysis showcased negative charges, with Ca-CAP exhibiting lower negativity. XRD highlighted increased crystallinity in Ca-CAP due to calcium crosslinking. Minimal impact on RBC properties was observed with both polymers compared to the positive control as water for injection (WFI). Ca-CAP exhibited improved viscosity, strength, controlled swelling, and erosion, allowing prolonged drug release compared to CAP. Stability studies confirmed consistent six-month drug release, emphasizing Ca-CAP’s potential as a stable, sustained drug delivery system over CAP. Robustness and accelerated stability tests supported these findings, underscoring the promise of Ca-CAP in controlled drug release applications.